Journal of Pharmacy Practice and Community Medicine logo

Journal of Pharmacy Practice and Community Medicine

Volume 6, Issue 4

2021 · pp. 46–71 · 5 articles

Volume
6
Issue
4
Published
2021
Pages
46–71
Articles
5
Sections
2
ISSN
2455-3255
Journal
JPPCM

In this issue

Research Article

  1. Sunita Pawar, Atmaram Pawar

    pp. 46-52 · DOI: 10.5530/jppcm.2020.4.15 · 2021

    Objectives: The diabetes epidemic in India has placed it in the second position in having the largest number (77 million) of adults with diabetes, worldwide. Diabetes is a chronic progressive disease that can be effectiv…

  2. Yaser Mohammed Al-Worafi, Wafa Mohammed Alseragi, Khaled Mohamed Alakhali, Long Chiau Ming, Gamil Othman, Abdulsalam M Halboup, Sultan M. Alshahrani, Sami Mustafa Alshakhshir, Abdulkareem Mohammed Al-Shami, Majid Ali, Mansour Adam, Syed Wajid, Ramadan Mohamed Elkalmi

    pp. 53-56 · DOI: 10.5530/jppcm.2020.4.16 · 2021

    Objectives: This study was aimed to explore the knowledge and beliefs of patients in Ibb, Yemen, regarding generic medicines and identify factors affecting their use of these medicines. Methods: A mixed qualitative and q…

  3. Mirza Khan, Nafees Ahmed, Abdul Wahid, Syed Liaquat Ali Khan, Asad Khan, Zarka Akbar, Palwasha Bibi

    pp. 57-63 · DOI: 10.5530/jppcm.2020.4.17 · 2021

    Background: There is scarcity of published information about doctors’ knowledge, attitude and adherence with hypertension guidelines from Pakistan. Objectives: To evaluate doctors’ knowledge, attitude and objective adher…

  4. Azfar Akram, Qaiser Iqbal, Sajjad Haider, Rabia Ishaq, Fahad Saleem

    pp. 64-68 · DOI: 10.5530/jppcm.2020.4.18 · 2021

    Objectives: The current study aims to assess the perception towards use of online health-related information among hospital pharmacists practicing at public healthcare institutes of Quetta city, Pakistan. Methods: This w…

Case Report

  1. Article

    Gulnaz Bano, Abhishek Sharma

    pp. 69-71 · DOI: 10.5530/jppcm.2020.4.19 · 2021

    To date, no standard drug therapy has proven effective to counter COVID-19 disease. There are only hit and trial based on assumptions and weak evidence that are directing prescribing practices for asymptomatic to symptom…